|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/24 | |||
| C07K 16/46 |
| (11) | Patento numeris | 1711528 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04815598.0 |
| Europos patento paraiškos padavimo data | 2004-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-07-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/043541 |
| Data | 2004-12-23 |
| (87) | Numeris | WO 2005/062972 |
| Data | 2005-07-14 |
| (30) | Numeris | Data | Šalis |
| 532130 P | 2003-12-23 | US |
| (72) |
FUNG, Sek, Chung, US
MOYLE, Matthew, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | TREATMENT OF CANCER WITH NOVEL ANTI-IL 13 MONOCLONAL ANTIBODIES |
| TREATMENT OF CANCER WITH NOVEL ANTI-IL 13 MONOCLONAL ANTIBODIES |